Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Gennex Laboratories, at its meeting on June 4, 2025, approved the allotment of 40 lakh equity shares (face value INR 1 each) upon conversion of warrants held by Premier Fiscal Services Pvt. Ltd., a promoter group entity. The shares were issued on a preferential basis at INR 14.75 per share, bringing the total value of the allotment to approximately INR 5.9 crore. Post-allotment, Premier Fiscal Services' holding in the company rises from 3,75,38,000 shares (16.50%) to 4,15,38,000 shares (17.95%), marking an increase of about 1.45 percentage points in promoter group ownership. This is part of a previously announced preferential issue, with the warrant holders now exercising their right to convert warrants into equity shares.
Minor dilution for existing public shareholders as promoter group stake increases from 16.50% to 17.95%. Since warrants were already issued earlier, this conversion was expected and signals promoter group commitment to the company. Short-term stock reaction is likely muted as no fresh capital raise is involved beyond the pre-committed warrant exercise.